Two E-rosette-forming lymphoid cell lines
- PMID: 203546
- DOI: 10.1002/ijc.2910210207
Two E-rosette-forming lymphoid cell lines
Abstract
Two E-rosette (spontaneous rosette with sheep red blood cells)-forming lymphoid cell lines were established. One (HPB-ALL) was derived from a young male Japanese patient with acute lymphoblastic leukemia (ALL), and the other (HPB-MLT) was from a 62-year-old female Japanese patient with a leukemic T-lymphoid malignancy. Formation of E rosettes, absence of any immunoglobulin determinants, absence of EBNA (Epstein-Barr virus associated nuclear antigen) and very limited stimulating ability in mixed lymphocyte culture, were characteristics mostly identical with those of so far established T-cell-derived lymphoid cell lines, MOLT, CCRF-CEM, CCRF-HS-B2, RPMI-8402 and JM. Only HPB-MLT, however, has been derived from an aged patient with T-lymphoid malignancy.
Similar articles
-
Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma.Int J Cancer. 1977 May 15;19(5):621-6. doi: 10.1002/ijc.2910190505. Int J Cancer. 1977. PMID: 68013
-
Establishment of the Amsalem T-cell line from a patient with acute lymphoblastic leukemia. Expression of E-receptor-associated antigens in cells incapable of forming E-rosettes.Int J Cancer. 1985 Jan 15;35(1):27-33. doi: 10.1002/ijc.2910350106. Int J Cancer. 1985. PMID: 2981779
-
Disparity of mixed lymphocyte reactivity to cultured cells of human T and B lymphoid lines.J Natl Cancer Inst. 1975 Mar;54(3):557-62. J Natl Cancer Inst. 1975. PMID: 123598
-
The immunological classification of acute lymphoblastic leukemias.Cancer. 1978 Aug;42(2 Suppl):817-27. doi: 10.1002/1097-0142(197808)42:2+<817::aid-cncr2820420703>3.0.co;2-2. Cancer. 1978. PMID: 356954 Review.
-
Differentiation capacity and other properties of the leukemic cells of chronic lymphocytic leukemia.Immunol Rev. 1979;48:23-44. doi: 10.1111/j.1600-065x.1979.tb00297.x. Immunol Rev. 1979. PMID: 232686 Review. No abstract available.
Cited by
-
Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme.Proc Natl Acad Sci U S A. 1981 Feb;78(2):1219-23. doi: 10.1073/pnas.78.2.1219. Proc Natl Acad Sci U S A. 1981. PMID: 6785752 Free PMC article.
-
Expression of MHC class II in T cells is associated with increased HIV-1 expression.Clin Exp Immunol. 2000 Aug;121(2):324-31. doi: 10.1046/j.1365-2249.2000.01290.x. Clin Exp Immunol. 2000. PMID: 10931149 Free PMC article.
-
The Production, Quality Control, and Characterization of ZED8, a CD8-Specific 89Zr-Labeled Immuno-PET Clinical Imaging Agent.AAPS J. 2020 Jan 3;22(2):22. doi: 10.1208/s12248-019-0392-0. AAPS J. 2020. PMID: 31900688
-
Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.Proc Natl Acad Sci U S A. 1982 Apr;79(8):2649-53. doi: 10.1073/pnas.79.8.2649. Proc Natl Acad Sci U S A. 1982. PMID: 6283539 Free PMC article.
-
Expression of Pax5 gene in human haematopoietic cells and tissues: comparison with immunodeficient donors.Clin Exp Immunol. 1998 Feb;111(2):339-44. doi: 10.1046/j.1365-2249.1998.00509.x. Clin Exp Immunol. 1998. PMID: 9486401 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials